The North Shore-LIJ Health System announced today it is making an initial investment of $175 million to expand its cancer services throughout the New York metropolitan area.
Leaders in research, care, administration, finance, advocacy and legislation discuss the possibilities for telemedicine in parkinson’s disease treatment and cure.
With March designated as Colorectal Cancer Awareness Month, the North Shore-LIJ Cancer Institute is enrolling people who were recently treated for colon cancer in a polyp prevention study.
Training of Hampton University undergrads to focus on racial disparities in prostate cancer treatments
Collaboration to focus on research and development of antibodies for the treatment of systemic lupus erythematosus
The North Shore-LIJ Health System today announced today that George Raptis, MD, joined its Cancer Institute as vice president of the oncology network.
People who study or treat Alzheimer’s disease and its earliest clinical stage, mild cognitive impairment (MCI), have focused attention on the obvious short-term memory problems. But a new study suggests that people on the road to Alzheimer’s may actually have problems early on in processing semantic or knowledge-based information, which could have much broader implications for how patients function in their lives.
130,000-square-foot facility includes 115 beds for geriatric, adult and adolescent patients, an Alzheimer’s Disease Dementia Center, New Electroconvulsive Therapy Unit.
New Bay Shore, NY, facility to treat psychological wounds of military families, smooth the transition home for vets struggling with PTSD and other issues.
Walk to Paris aims to improve health, promote team-building.
North Shore-LIJ Health System today announced the creation of the New York Head and Neck Institute (NYHNI), a part of its head and neck surgery service line, and the opening of the Center for Cranial Base Surgery at Lenox Hill Hospital.
Researchers led by a senior investigator at Hofstra-North Shore LIJ School of Medicine and The Feinstein Institute for Medical Research have released initial findings from a first-of-a-kind clinical trial in adaptive radiotherapy (ART) for head and neck cancer.
This new study is a National Institute of Mental Health-funded randomized double-blind trial that was designed to test whether Omega-3 fatty acids improve clinical symptoms, and help adolescents and young adults (ages 12 to 25) who are at elevated risk for severe psychiatric disorders function better in school, work and other social environments.
Women who inherit the cancer genes BRCA1 or BRCA2 from their paternal lineage may get a diagnosis a decade earlier than those women who carry the cancer genes from their mother and her ancestors, according to a new study by researchers at the North Shore-LIJ Heath System's Monter Cancer Center in Lake Success, NY.
The American Journal of Industrial Medicine recently published a study showing that World Trade Center (WTC) responders suffer from asthma at more than twice the rate of the general U.S. population as a result of their exposure to the toxic dust from the collapse of the WTC towers in 2001.
LIJ Medical Center has been designated as an Academic Center of Excellence for minimally invasive surgery in gynecologic oncology and gynecology by the American Institute of Minimally Invasive Surgery (AIMIS). LIJ is the first hospital in New York and the entire Northeast region to achieve this prestigious national designation.
Scientists have identified a surprising new role for a new type of T cell in the immune system: some of them can be activated by nerves to make a neurotransmitter (acetylcholine) that blocks inflammation. The discovery of these T cells is novel and suggests that it may be possible to treat inflammation and autoimmune diseases by targeting the nerves and the T cells.
Scientists at The Feinstein Institute for Medical Research discovered a molecule called c-Abl that has a known role in leukemia also has a hand in Alzheimer’s disease.
New program that seeks to improve the quality of complex processes by identifying and removing the causes of errors.
A multi-center gene therapy trial for patients with advanced Parkinson’s disease demonstrated reduced symptoms of the progressive movement disorder, according to a new study published in Lancet Neurology.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right